early-onset prostate cancer
Men's Health vs PSA: Panel Saves 30%
PSA tests miss up to 40% of early prostate cancers, while a multibiomarker blood panel can flag the disease weeks before symptoms appear. In my reporting, I’ve seen the gap widen as younger men remain invisible to traditional screening, prompting a search for smarter tools. Medical Disclaimer: This article